https://www.selleckchem.com/pr....oducts/nivolumab.htm
Four classifiers were evaluated for predicting a future cancer diagnosis where Random Forest achieved the best results with an AUC of 0.70 from a year before diagnosis up to 0.97 one day before diagnosis. We conclude that our approach is sound and had excellent discrimination at diagnosis, but only modest discrimination capacity before this point. Since our study objective was earlier disease prediction than such, we propose further work should consider extending patient histories through e.g. the integration of primary health records
Like
Comment
Share
